420 with CNW — Does CBD Support Post-Cancer Recovery?

You have probably heard about CBD, either from the media or in person, especially in regard to its medical potential. Cannabidiol (“CBD”) came into the limelight when the 2018 farm bill federally legalized the cultivation and sale of industrial hemp and its derivatives, including CBD. Although hemp is in the cannabis family, CBD extracted from legal industrial hemp will not intoxicate you. However, CBD still shares plenty of medical properties with THC, the main psychoactive agent in marijuana, and several studies have found that cannabidiol can aid in post-cancer recovery.

So how exactly does taking CBD aid in post-cancer recovery? It all boils down to potent anti-inflammation and antioxidant properties. CBD is most commonly used to address issues such as chronic pain, anxiety, depression, nausea and insomnia. Some studies have also found that cannabinoids such as CBD can inhibit tumor growth and reduce tumor invasion. However, more research is needed before we can conclusively state that CBD is an effective anti-cancer treatment. However, at the moment, cannabinoid does look to be able to support post-cancer recovery.

Coincidentally, most of the adverse symptoms caused by cancer treatments such as radiation and chemotherapy can be treated by CBD treatment. These symptoms include nausea, insomnia, loss of appetite and neuropathic pain. Recovering from cancer can be brutal as the treatments aren’t easy on the body. Lack of appetite, for instance, can significantly reduce your food intake, reducing your energy levels and actually hindering your recovery. Since CBD is known to stimulate appetite, individuals undergoing cancer treatment can use it to maintain sufficient nutrient intake and give their bodies the energy it needs to recover.

This is the same for insomnia, which will not only make you feel tired and fatigued but can also put your health at even more risk. CBD is also thought to be a pain reliever, and it can be effective against the sometimes severe pain cancer patients feel. All cannabinoids, including CBD and THC, create their therapeutic effects by interacting with the endocannabinoid system (“ECS”), a part of the nervous system that’s in charge of regulating processes such as hunger, sleep and pain. Essentially, the ECS is a system that works to maintain homeostasis, or the body’s internal balance.

If you would like to use CBD to aid in cancer recovery, make sure to speak to your doctor first. Additionally, you should not ditch your cancer medication for CBD; while some studies have found that it has anti-cancer effects, it isn’t an effective treatment against cancer.

Such cannabis-based treatments may stand a higher chance of being beneficial when taken using an IoT-enabled dose-measuring device such as those produced by RYAH Group Inc. (CSE: RYAH) and other such companies.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Marijuana Industry Expects to See Spike in Sales This Holiday Season

The holiday season is here, and while most industries will see a slight decline in profits, marijuana sales are expected to go up. Reports from Leaflink show that cannabis sales rose by more than 30% in the week leading up to Christmas last year, in comparison to the previous four weeks of 2020. Additionally, sales on Christmas Eve last year rose by 61%, in comparison to the previous four Thursdays.

Leaflink, a unified marijuana platform, also reports that on the days leading up to Green Wednesday November, they saw an increase of more than 10% in sales. If sales from Green Wednesday are any indication, the cannabis market will see a significant jump in sales this year.

Glass House Brands Inc., a company based in California, also saw an increase of more than 40% in its sales across its locations on Green Wednesday, compared to the 2020 sales day. This was the same case for Jushi Holdings Inc. and Beyond Hello, its retail brand, which saw an increase of more than 110% in Green Wednesday sales, in comparison to the prior year’s sales.

The rep for Terrasana, a dispensary chain in Ohio, stated recently that the company expects December to be its highest-grossing month in 2021. Expectations grew after Terrasan increased transactions and revenue by 33% and 23% respectively in November.

eCommerce retailers also expect sales to increase this month. Tyler Browne, the owner of To the Cloud, an online retail vapor store based in California, stated that he expected sales in December to be good for the whole marketplace, in particular those looking to begin anew next year. He added that while sales for 4/20 in April were great, marijuana was becoming mainstream, which caused the weed holiday to be less impressive because every day was 4/20 for most consumers.

However, not every part of the marijuana industry sees an increase in sales during the holidays. For instance, cultivators are busiest in April because that’s the time for harvest and in October, when new cultivators are introduced. Once the plant is harvested, other companies are given the task of processing and packaging the product.

Grove Bags is one of the companies that does this. Chief of Staff Jeffrey Eisenstodt revealed that the company’s busy season began in the summer and peaked in September or October. He added that while the holiday season was good for marijuana purchasing, it marked the end of the harvest season and a downturn in demand for packaging.

Not every company is likely to see a meaningful spike in their sales activity this festive season, unless they have gone out of their way to manufacture the best possible products while also nurturing their brand in the way that some leading entities, such as Cannabis Strategic Ventures Inc. (OTC: NUGS), have been doing.

NOTE TO INVESTORS: The latest news and updates relating to Cannabis Strategic Ventures Inc. (OTC: NUGS) are available in the company’s newsroom at http://cnw.fm/NUGS

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) Ranks in List of Top 101 Canadian F&B Startups and Companies

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), an emerging leader in innovative health and wellness beverages and products, has been named one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. The ranking recognizes the company’s leadership position within both the food & beverage and cannabis product categories. Companies listed in the rankings include cutting-edge startups and established brands alike, but each company is known for innovation within their sector, exceptional growth and societal impact. BevCanna was within the group of selected companies that exhibited exceptional performance. In addition, BVNNF was also included within the list of the Top 101 Cannabis Startups and Companies in Canada, a list of innovators and growth companies within the Canadian cannabis industry. In addition, the company has appointed Howard Blank and Douglas Mason as members of the audit committee resulting from their respective appointments as directors at the annual general and special meeting of the shareholders on November 24, 2021. “It’s both an honor and a reflection of the BevCanna team’s expertise and dedication, to be included within the sphere of other premier Canadian food and beverage companies, including Ritual, Goodfood, Flow Water, Chef’s Plate and David’s Tea,” said BevCanna CEO Marcello Leone in the press release. “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy of developing innovative, highly-customized beverage products that appeal to a range of target markets, including value, craft and premium positioning, for both our in-house brands and our white-label clients.” To view the full press release, visit https://cnw.fm/neDae About BevCanna Enterprises Inc. BevCanna Enterprises is a diversified health and wellness beverage and natural products company. BevCanna develops and manufactures a range of alkaline, plant-based and cannabinoid beverages and supplements for both in-house brands and white-label clients. With decades of experience creating, manufacturing and distributing iconic brands that resonate with consumers on a global scale, the BevCanna team demonstrates an expertise unmatched in the nutraceutical and cannabis-infused beverage categories. Based in British Columbia, BevCanna owns a pristine alkaline spring water aquifer and a world-class, 40,000-square-foot, HACCP-certified manufacturing facility, with a bottling capacity of up to 210 million bottles annually. BevCanna’s extensive distribution network includes more than 3,000 points of retail distribution through its market-leading TRACE brand, its Pure Therapy natural health and wellness e-commerce platform, its fully licensed Canadian cannabis manufacturing and distribution network, and a partnership with number-one U.S. cannabis beverage company Keef Brands. For more information about the company, please visit www.BevCanna.com. NOTE TO INVESTORS: The latest news and updates relating to BVNNF are available in the company’s newsroom at http://cnw.fm/BVVNF About CannabisNewsWire CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge. To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only) For more information please visit https://www.CannabisNewsWire.com Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer Do you have questions or are you interested in working with CNW? Ask our Editor CannabisNewsWire (CNW) Denver, Colorado www.CannabisNewsWire.com 303.498.7722 Office Editor@CannabisNewsWire.com CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Florida Bipartisan Bill Seeks to Reform Medical Cannabis Program

State cannabis laws have always been tricky; in most cases, they arise from voter-approved initiatives, and their structures are usually determined by lawmakers who largely aren’t fans of cannabis. The result is a lot of push and pull between Republicans and Democrats while consumers sometimes have to contend with a wide variety of subpar, contaminated and even unsafe cannabis products. In Florida, both sides of the political spectrum are setting aside their differences to work on a major cannabis reform bill that would potentially fix an oversight left by the 2018 farm bill.

The farm bill legalized the cultivation and sale of industrial hemp and its derivatives, including CBD. Cannabidiol (“CBD”) has been found to have a variety of medical properties and has even been approved for use in an epilepsy drug called Epidiolex. The federal legislation described industrial hemp as cannabis with less than 0.3% delta-9 THC and required that all hemp products have the same amount of delta-9 THC. However, thanks to a loophole in the bill, hemp products with plenty of delta-8 THC aren’t as regulated, although delta-8 THC is also psychoactive and can cause intoxication.

On top of increasing delta-8 regulation, HB 679 would expand the use of telehealth, restrict medical cannabis advertising, increase the validity of medical cannabis cards from a year to two, and restrict medical marijuana companies from flipping inactive licenses for profit. The bill would also expand testing protocols, establish a Medical Marijuana Testing Advisory Council and require that physicians take a six-hour training course before they can recommend medical marijuana. Representatives Andrew Learned and Spencer Roach are the legislation’s sponsors.

Learned says that Florida’s legislature hasn’t advanced the state’s cannabis sector over the past five years, but their bill is the first step and more are in development. So while the FDA still hasn’t evaluated delta-8 products, HB 679 would require businesses that deal in these products to register them with state authorities and limit their sales to Floridians 21 years of age and older. Agriculture Commissioner Nikki Fried says that the state has to make sure it protects medical cannabis consumers and welcomes the bill’s clarity regarding issues such as product testing.

Learned’s and Roach’s bill is a true compromise, lobbyists and lawmakers say. Both sides won’t get everything they want, but at the end of the day, the bill would be a win for Florida’s medical cannabis program. For example, it doesn’t include a controversial THC cap first introduced by Roach, a Republican, as well as measures including offering workplace protections for medical cannabis patients that are championed by some Democrats. Senators Joe Gruters and Shevrin Jones will soon file a companion bill in the Senate.

These proposed reforms could give entities such as Flora Growth Corp (NASDAQ: FLGC) added impetus to grow due to the additional streamlining of the regulatory regime in the state.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — ONDCP Director Open to Harm-Reduction Intervention to Manage Overdose Crisis

Top health officials in the Biden administration have been promoting harm reduction for a while now. Recently, the director of the Office of National Drug Control Policy, Rahul Gupta, stated that exploring every option to decrease deaths caused as a results of overdoses was crucial, noting that the options included allowing sites for the safe consumption of illicit substances if evidence supported their effectiveness.

When asked about the launch of a pair of safe consumption sites in the state of New York late last month and whether he supported it, Gupta stated that he was interested in examining the data and science behind the new harm-reduction practices being implemented. He explained that harm reduction was an important tool, given the current crisis, which was why the administration had made it part of its policy.

While the Biden administration’s policy on safe injection sites is still a bit vague, the director’s comments show an openness to harm-reduction intervention. Safe injection sites are controversial in the United States as the federal statute under the constitution known as the crack house statute makes it illegal to use a location to manufacture, distribute or consume controlled substances.

During a briefing on federal harm-reduction grants, Secretary Xavier Becerra of the Department of Health and Human Services was also asked about overdose prevention facilities. When asked about harm-reduction centers, Becerra stated that the administration was examining ways to support research on the efficacy of new practices, noting that they were focused on whether these practices were also effective in real world settings. He added that stigma only induced fear, secrecy and silence, which made it harder to save the lives of those suffering from addiction.

As the conversation on substance misuse and drug policy evolves, the support for the establishment of harm reduction centers continues to grow. A coalition comprised of 80 former and current law enforcement officials and prosecutors have filed a brief that urges the Supreme Court to look into the Safehouse consumption case again. The case involves a Philadelphia not-for-profit organization known as Safehouse, which was sued by the Department of Justice in 2019 to prevent the launch of its safe injection site. Earlier this year, the Supreme Court declined a request to hear a case on the legality of the establishment of said facilities.

Apart from the state of New York, Gov. Daniel McKee of Rhode Island has also signed a measure to establish a safe injection site pilot program.

It might also be beneficial to look into potential benefits marijuana products from licensed actors such as American Cannabis Partners can have in the fight against the overdose crisis since the situation needs concerted efforts from all possible directions.

NOTE TO INVESTORS: The latest news and updates relating to American Cannabis Partners are available in the company’s newsroom at https://cnw.fm/ACP

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Focused on Florida Ahead of ‘Massive Medical Marijuana Boom’

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis sector operator, is off to a strong start in building its high-quality flower resource for product inventory at dispensaries throughout Florida. The company has been working to launch growing operations at its Apopka, Florida-based cultivation location, adding 19,200 square feet of production expected to deliver $30 million in annual revenues. The pods were approved by the state health department’s Office of Medical Marijuana Use (“OMMU”) with licensing granted just before Halloween, with five already in use for plant growth at that time with the remainder fast-tracked for output. According to a recent article, “Red White & Bloom is focused on Florida ahead of a ‘massive medical marijuana boom’ expected to sweep the state as prohibitionist policies recede (https://cnw.fm/dZ7My).” “We have nurtured our strains to produce high quality flower in the Florida climate while producing high yields, industry-leading THC percentages and superior terpene content,” said Jim Frazier, the general manager of Red White & Bloom’s Florida cultivation subsidiary. “The grow pods provide us with speed to market capabilities which are needed for RWBFL to meet and exceed expectations for generating profitable revenue early in 2022.”

To view the full article, visit https://cnw.fm/Gt8zV

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Florida, Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://cnw.fm/RWBYF

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Major Kombucha Company Ventures into Marijuana Space

The most popular Kombucha brand globally, GT’s Living Foods is venturing into a new market: the marijuana industry. The firm is launching a marijuana–infused brew known as Cannabliss in the state of California.

GT’s Living Foods has operated as part of the health and wellness sector for more than 20 years. It currently holds roughly 47% of the category market share through continued innovation. The brand has been brewing healthy beverages for more than two decades, which makes its move to create its first marijuana-infused line a well-calculated one.

The CEO and founder of the company, GT Dave, stated that the company couldn’t ignore the power of the marijuana plant as it continued to innovate with plant-based wellness, noting that the plant’s power went beyond recreational and aligned with the company’s belief that plants and food are medicine. GT Dave explained that when combined with other natural adaptogens, marijuana provided various healing properties and positive benefits.

With the introduction of its cannabis-infused beverage to the market, the company hopes to unleash the power of the cannabis plant so consumers can obtain some of its body health and mind benefits.

The company’s Cannabliss line combines CBD and THC with prebiotics from apple cider vinegar, full-spectrum marijuana and a blend of mushrooms, in order to nourish the gut. THC (tetrahydrocannabinol) is the primary psychoactive compound in marijuana that induces a high. On the other hand, CBD (cannabidiol) is a common active ingredient found in marijuana. Unlike THC, this compound doesn’t cause any highs.

The beverage will be available in two varieties: wild and mild. The two come in these flavors:

Cannabliss wild ginger haze, which has a lemon and ginger flavor and has been infused with 3 mg of CBD and 7 mg of THC.
Cannabliss mild piña express, which has a pineapple flavor and has been infused with 7 mg of CBD and 3 mg of THC

Cannabliss will be available for purchase by consumers at various dispensaries in the state of California.

The company is one of the largest mainstream beverage companies to venture into the marijuana industry. Other big companies participating in the industry include Constellation Brands, which has injected billions into Canopy Growth.

Earlier this year, Canopy Growth began selling its CBD-infused sparkling water, Quatreau, which comes in four flavors: blueberry with acai, ginger with lime, passion fruit with guava and cucumber with mint.

The stage looks set for stiff competition between the new kid on the block and established cannabis drink companies such as BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC).

NOTE TO INVESTORS: The latest news and updates relating to BevCanna Enterprises Inc. (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC) are available in the company’s newsroom at http://cnw.fm/BVNNF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — How the Marijuana Industry Is Leveraging the CPG Technique

The state-legal cannabis industry has come quite a long way, all things considered. After decades of racially motivated prohibition and the proliferation of anti-cannabis propaganda, Americans in dozens of states can now legally access the controversial plant. Dozens of states now allow medical marijuana while nearly 20 states have passed recreational cannabis legislation, building a massively lucrative state-legal cannabis market and attracting plenty of new businesses. Coincidentally, a lot of the talent drawn to America’s nascent cannabis industry is from the consumer packaged goods (“CPG”) space, and these experienced professionals are applying techniques they learned to the young but lucrative sector.

Consumer packaged goods companies have been around for decades, and they have pretty much standardized the techniques for taking a CPG from initial development all the way to profitability. But since the cannabis industry has legal and regulatory considerations that most other industries don’t, mostly thanks to its federal status as a Schedule I Controlled Substance, leaders in the cannabis space have been careful with how they apply CPG techniques. Presently, most forward-thinking cannabis companies are using a variety of different form factors collectively called Cannabis 2.0.

While the industry was still in its infancy, Cannabis 1.0 was the main model. It mainly consisted of cannabis flower lumped into two categories: indica and sativa. There was limited product differentiation and few standards for product safety, but as the industry grew, states began setting regulations for product quality, the market saw an influx of different cannabis products and the customer base grew. Leaders in the cannabis space are now leveraging CPG techniques to ensure their products remain marketable and relevant as the industry matures.

With the cannabis market now proliferated with all kinds of products, including edibles, concentrates, and beverages, branding has become especially crucial, says Greenlane Holdings CEO Nick Kovacevich. Branding will allow cannabis companies to create differentiation and better connect with their customers. This will help cannabis companies carve out portions of the ever-increasing cannabis market as more consumers purchase cannabis products. And to cater to the growing consumer base, Cannabis 2.0 products are diversified to meet different consumer needs and wants, just as in the CPG space.

Curaleaf CEO Joseph Bayern is also chiming in, noting that CPG companies achieve profitability by understanding their customers’ needs and developing better products than their competitors to meet those needs. Cannabis companies that are looking to expand past state borders have also been held back by the patchwork regulations governing America’s state-legal cannabis space. To work around this, multistate operators are installing individual operations that can produce products that meet local, state and municipal standards and ensure customer satisfaction.

Companies in the cannabis space are also adopting CPG strategies such as upper and lower funnel marketing and good-better-best pricing that have had success for consumer packaged goods companies, says Adam Grablick, CEO of Kiva Confections. Moving forward, he says, cannabis companies will need to focus on positioning, segmentation, product points-of-difference, and evolving consumer needs and wants to ensure their brands stay competitive.

As the industry grows over the coming years, we are likely to see a lot more innovation from sector players such as Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) as the fight to consolidate market dominance intensifies.

NOTE TO INVESTORS: The latest news and updates relating to Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) are available in the company’s newsroom at https://cnw.fm/RWBYF

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – RYAH Group Inc. (CSE: RYAH) to Collaborate with OMNI Medical Services for Cannabis Study in Treatment of COVID-19

RYAH Group (CSE: RYAH), a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry, has announced plans for a U.S. clinical study focused on treatment COVID-19. RYAH will be partnering with OMNI Medical Services to perform the U.S.-based clinical study evaluating patients using inhalation of medical cannabis to both treat and prevent the coronavirus. The study, which will run for five years, will involve the use of RYAH’s Smart Inhaler devices and will involve up to 11,000 of OMNI’s patients across the country. Phase 2 of the study is planned for Q2 2022, with an end date in 2024. The strategic plan also includes presenting gathered data to the FDA as part of the effort for national legalization of cannabis for medical use. “We’re excited to be working with OMNI on this thoughtful and timely study on the evaluation of novel preventative and treatment measures related to inflammatory effects from COVID-19,” said RYAH Group CEO Gregory Wagner in the press release. “RYAH is honored to be selected to participate in this important project with OMNI, to be contributing to valuable data aggregation, and to raise our understanding of plant-based inhalation methods on potentially addressing anti-inflammatory effects of COVID-19.”

To view the full press release, visit https://cnw.fm/ODy0V

About RYAH Group Inc.

RYAH is a connected device and big data and technology company focused on valuable predictive analysis in the global medical plant and nutraceutical intake industry. Its robust artificial intelligence platform aggregates and correlates Health Insurance Portability and Accountability Act (“HIPAA”)-compliant patient data, which is intended to help doctors and patients personalize plant-based treatments to better predict treatment outcomes. The data collection is relevant for clinics, doctors, dispensaries and pharmaceutical companies, as well as licensed processors (“LPs”) to monitor and manage formulation effects on patients and demographics. RYAH gathers deep and insightful data on the complete patient session and formulation life cycle. For more information about the company, please visit www.RyahGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to RYAH are available in the company’s newsroom at https://cnw.fm/RYAH

About CanadianCannabisWire

CanadianCannabisWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CanadianCannabisWire.com

Please see full terms of use and disclaimers on the CanadianCannabisWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CanadianCannabisWire (CNW)
Toronto, Ontario
www.CanadianCannabisWire.com
905.674.5977 Office
Editor@CanadianCannabisWire.com

420 with CNW — Patients, Doctors Now Discussing Medical Marijuana

Cannabis has always been a controversial topic. Even as dozens of states passed medical cannabis regulations and more studies found that the plant had plenty of medical potential, the stigma around cannabis remained. Not only did this prevent important conversations surrounding topics such as the disproportionate effects of cannabis prohibition from happening early enough, but it also kept patients from talking about cannabis with their doctors, even if they stood to benefit a great deal from marijuana-based treatment. However, results from a new survey indicate that this may be changing.

Healthcare company Cannaceutica conducted a survey of 445 healthcare providers and asked them whether their patients had talked to them about cannabis or requested medical marijuana treatments in the past 30 days. More than 70% said their patients had made inquiries about cannabis treatments in the past month, with the patients asking about cannabis far more often compared to other alternative pain treatments such as physical therapy, massage and acupuncture. The healthcare providers who took part in the online survey included general practitioners, nurse practitioners, rheumatologists, pain-management specialists and neurologists.

The results of the survey reveal a drastic shift in how people view cannabis. Traditionally, patients who could benefit from cannabis treatments have refrained from asking their doctors about medical marijuana for fear of being seen as potheads or being dropped by their doctors. Similarly, health practitioners weren’t comfortable discussing cannabis with their patients as it is still federally prohibited and hasn’t been sufficiently studied and researched. In fact, national polls from 2018 and 2019 revealed that less than 40% of patients discussed cannabis use with their doctors.

Fortunately, today more patients are willing to raise the option of medical cannabis treatments with their healthcare providers. According to Cannaceutica’s survey, 81% of healthcare providers believe cannabis will play a role in chronic pain management in the future. Still, only one person in four healthcare practitioners would recommend medical marijuana to their patients currently, mostly due to the scarcity of reliable cannabis research as well as the legal and regulatory issues surrounding the plant. With several lawmakers working to pass legislation that would federally decriminalize cannabis, there is a chance the federal government could legalize cannabis in the near future.

If that happens, 74% of the survey participants said they would endorse a medical cannabis treatment plan. They would also be more comfortable recommending medical marijuana if there was more scientific research and documentation about the benefits and risks of using cannabis as a chronic pain treatment. At the moment, 64% said they obtained most of the cannabis information they knew from their patients, 44% from the internet and 40% from medical journals.

Now that patients are talking to their doctors about medical cannabis, it may not be long before cutting-edge enabling technology such as the smart inhalers manufactured RYAH Group Inc. (CSE: RYAH) become commonplace among patients who are collaborating with their doctors on matters of managing various health conditions.

NOTE TO INVESTORS: The latest news and updates relating to RYAH Group Inc. (CSE: RYAH) are available in the company’s newsroom at https://cnw.fm/RYAH

About CNW420

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.